Jose Leal presented HepatoPredict at the ESSO 40, in the session Future Oncology, where he had the opportunity to discuss HepatoPredict and its validation roadmap with experts from different institutions.

Jose Leal presented HepatoPredict at the ESSO 40, in the session Future Oncology, where he had the opportunity to discuss HepatoPredict and its validation roadmap with experts from different institutions.
Related Posts
👏💪 It’s out! Our latest study addresses a critical need in gastroenterology: early and accurate identification of Barrett’s Esophagus (BE)
We’re excited to announce that HepatoPredict, our CE-IVD prognostic tool to assess hepatocellular carcinoma (HCC) recurrence in the context of
HepatoDetect Shows Strong Potential for Early HCC Detection HepatoDetect, our AI-driven liquid biopsy platform designed for the early detection of
Now partnering with global institutions and investors to scale innovation where it matters most. Ophiomics is building the world’s first